Diffuse Midline Glioma Histone 3 K27M WHO Grade IV
1 clinical trials · Condition
◉ Watch Diffuse Midline Glioma Histone 3 K27M WHO Grade IV
| Record | Firm | Date |
|---|---|---|
| International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013) (NCT03243461) | University of Göttingen | 2018-07-17 |
Track Diffuse Midline Glioma Histone 3 K27M WHO Grade IV automatically
Every clearance here is in the API, with alerts when new ones post.